High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study

Title
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study
Authors
Keywords
Endometrial cancer, Paclitaxel, Stathmin
Journal
GYNECOLOGIC ONCOLOGY
Volume 146, Issue 2, Pages 247-253
Publisher
Elsevier BV
Online
2017-05-20
DOI
10.1016/j.ygyno.2017.05.017

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started